MARKETS
Earnings

DataMEDS AI Q2 EPS $(7.13) Down From $(5.40) YoY, Sales $1.780M Down From $7.791M YoY

Aug 17, 2026 · 09:05 AM ET· updated 2h ago

DataMEDS AI (NASDAQ:MEDS) reported quarterly losses of $(7.13) per share. This is a 32.04 percent decrease over losses of $(5.40) per share from the same period last year. The company reported $1.780 million in sales

Share
Why It Matters

DataMEDS AI lost more money per share this quarter than last year, and its sales shrank by more than half. When a company's losses grow and its money coming in shrinks fast, it's a sign to watch whether they can turn things around soon.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.